FBTAX Holdings Information

FBTAX is a mutual fund with a total of 114 individual holdings. The top holdings are AbbVie stock at 14.76%, Gilead Sciences at 6.57%, Alnylam Pharmaceuticals at 5.39%, Dianthus Therapeutics at 3.57%, and Insmed at 3.47%.

Total Holdings

114

Top 10 Percentage

50.03%

Asset Class

Equity

Fund Category

Health

Assets

1.90B

Forward PE Ratio

19.47

Breakdown by Asset Class

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	ABBV	AbbVie Inc.	14.76%	1,289,880
2	GILD	Gilead Sciences, Inc.	6.57%	929,200
3	ALNY	Alnylam Pharmaceuticals, Inc.	5.39%	339,486
4	DNTH	Dianthus Therapeutics, Inc.	3.57%	730,062
5	INSM	Insmed Incorporated	3.47%	617,200
6	ARGX	argenx SE	3.39%	77,200
7	COGT	Cogent Biosciences, Inc.	3.37%	1,834,818
8	SYRE	Spyre Therapeutics, Inc.	3.31%	855,647
9	ASND	Ascendis Pharma A/S	3.17%	269,225
10	BIIB	Biogen Inc.	3.03%	294,100
11	RVMD	Revolution Medicines, Inc.	2.48%	299,500
12	NUVL	Nuvalent, Inc.	2.39%	412,264
13	AMGN	Amgen Inc.	2.39%	135,103
14	ORKA	Oruka Therapeutics, Inc.	2.27%	737,386
15	PCVX	Vaxcyte, Inc.	2.17%	801,529
16	APGE	Apogee Therapeutics, Inc.	1.95%	452,639
17	AMLX	Amylyx Pharmaceuticals, Inc.	1.84%	2,433,200
18	VRDN	Viridian Therapeutics, Inc.	1.65%	1,782,464
19	MRNA	Moderna, Inc.	1.59%	640,800
20	n/a	Fidelity Cash Central Fund	1.47%	27,916,801
21	ROIV	Roivant Sciences Ltd.	1.22%	776,700
22	PRAX	Praxis Precision Medicines, Inc.	1.11%	60,500
23	KNSA	Kiniksa Pharmaceuticals International, plc	1.06%	417,600
24	NTRA	Natera, Inc.	1.05%	89,400
25	NAMS	NewAmsterdam Pharma Company N.V.	1.04%	586,400

Showing 25 of 114 holdings

Subscribe to see the full list

Activate Now

As of May 31, 2026